Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: A dopamine hypothesis

Documenta Ophthalmologica

Volumn 105, Issue 1, 2002, Pages 41-49

  Fornaro, Pantaleo ^a   Calabria, Giovanni ^a   Corallo, Guido ^a   Picotti, Giovanni B ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antipsychotics; Dopamine; Retinal receptors; Retinopathy; Thioridazine

Indexed keywords

BROMOCRIPTINE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ENZYME; HALOPERIDOL; LUZINDOLE; MELANIN; MELATONIN; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; RACLOPRIDE; RECEPTOR SUBTYPE; REMOXIPRIDE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; DOPAMINE RECEPTOR;

CHOROID CAPILLARY LAYER; DRUG ABSORPTION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; ENZYME ACTIVITY; EYE TOXICITY; HISTOLOGY; HUMAN; MENTAL DISEASE; NONHUMAN; PATHOGENESIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; RECEPTOR AFFINITY; RETINA DEGENERATION; RETINA DYSTROPHY; RETINITIS PIGMENTOSA; REVIEW; SYMPTOMATOLOGY; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; METABOLISM; RETINA;

ANIMAL; ANTIPSYCHOTIC AGENTS, PHENOTHIAZINE; DOPAMINE; DOPAMINE ANTAGONISTS; HUMAN; MELATONIN; RECEPTORS, DOPAMINE; RETINA; RETINAL DEGENERATION; THIORIDAZINE; ANIMALS; ANTIPSYCHOTIC AGENTS; HUMANS;

EID: 0035989275     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015768114192     Document Type: Review

References (59)

1. Adverse reactions of antipsychotic drugs
2. Ocular adverse effects of neuropsychiatric agents. Incidence and management
3. A clinical study of pigmentary change in cornea and lens in chronic Chlorpromazine therapy
4. Skin and eye changes associated with Chlorpromazine therapy
5. Ocular toxic changes associated with Chlorpromazine and Thioridazine
6. Eye and skin changes in psychiatric patients treated with Chlorpromazine
7. Pigmentary retinopathy and iridocycloplegia in psychiatric patients
8. Newer phenothiazine drugs in treatment of nervous disorders
9. Pigmentary retinopathy in patients receiving high doses of a new phenothiazine
10. Retinal pigmentation in a patients receiving Thioridazine
11. Thioridazine (Mellaril) retinopathy
12. Thioridazine pigmentary retinopathy
13. Ocular complications related to phenothiazines
14. Drug induced macular disease
15. Pigmentary retinopathy due to Thioridazine or Mellaril
16. Thioridazine retinopathy within the upper dosage limit
17. Pigmentary retinopathy associated with low dose Thioridazine treatment
18. Chorioretinopathy associated with Thioridazine therapy
19. Is Thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function
20. Mellaril intoxication of retina with full restitution of function
21. The concentration of phenothiazines in the eye of experimental animals
22. Progression of Thioridazine induced retinopathy
23. Ocular and cutaneous effects of chronic phenothiazine therapy
24. L'elettroretinografia come possibile metodo di studio nell'attività dopaminergica nell'uomo
25. Electroretinography (ERG) as a tool of investigation in human psychopharmacology. Electroretinographic changes induced by a combination of Levo-DOPA and Carbi-DOPA
26. Recent advances on the origin and modulation of the b-wave of the electroretinogram
27. Electroretinography (ERG) as a tool of investigation on dopaminergic activity in man. ERG changes induced by Perphenazine and Bromocriptine
28. The effects of levodopa and haloperidol on flash and pattern ERG and VEPs in normal humans
29. Electroretinographic effects induced in humans by psychopharmacological agents
30. The origin of b-wave and slow potentials in the mammalian ERG
31. 4 dopamine receptor
32. 2-like receptor subtype in the rat retina: Biochemical and histochemical evidence
33. 4 receptors analysis?
34. Dopamine inhibits melatonin release in the mammalian retina: In vitro evidence
35. Clinical ultrastructural study of Thioridazine retinopathy
36. 3H-Dopamine in the retina in vivo
37. Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the cat, monkey and human retina
38. 4 receptors coupled to adenylate cyclase
39. 2 receptors in rat retina
40. 2 receptors
41. Possible indication of dopaminergic blockade in man by electroretinography
42. Toxicology of the human retinal pigment epithelium
43. Primary pigmentary degeneration and its association with neurological diseases
44. 4 receptor
45. 2-agonist Bromocriptine prolongs functional survival of dystrophic RCS rat retinas
46. Melatonin increases serotonin-N-acetyl-transferase activity and decreases dopamine synthesis in light-exposed chick retina: In vivo evidence supporting melatonin-dopamine interaction in retina
47. Rôle de l'epiphyse dans la migration du pigment epithelial retinien chez quelques teleosteens
48. Pigment aggregation by melatonin in the retinal pigment epithelium and choroids of guinea pigs 'Cavia porcellus'
49. Circadian regulation of retinomotor movements. Interaction of melatonin and dopamine in the control of cone length
50. Rod photoreceptor disc shedding in eye cups: Relationship to bicarbonate and aminoacids
51. Melatonin increases photoreceptor susceptibility to light damage
52. Dopamine receptor pharmacology
53. The melatonin antagonist Luzindole protects retinal photoreceptors from light damage in the rat
54. Low retinal dopamine and serum prolactin levels indicate an inherited dopaminergic abnormality in BW rats
55. Pigmentary degeneration of the retina in heredodegenerative neurological diseases
56. Electroretinographic abnormalities in idiopathic Parkinson's disease and the effect of levodopa administration
57. Meccanismi molecolari nell'azione dei nuovi farmaci antipsicotici
58. N-n-Propyl-substituted 3-(dimethylphenyl) piperidines display novel discriminative properties between dopamine receptor subtypes: Synthesis and receptor binding studies
59. Neurobiology of retinal dopamine in relation to degenerative states of the tissue